These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 10939758)

  • 1. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.
    Agha-Razii M; Amyot SL; Pichette V; Cardinal J; Ouimet D; Leblanc M
    Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous veno-venous hemofiltration in acute renal insufficiency].
    Freudiger H; Lévy M; Suter P; Favre H
    Nephrologie; 1990; 11(3):129-33. PubMed ID: 2234267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An exceptionally severe hyperuricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS)].
    Basile C; Montanaro A
    G Ital Nefrol; 2003; 20(5):525-8. PubMed ID: 14634969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous veno-venous hemodiafiltration in children after cardiac surgery.
    Jander A; Tkaczyk M; Pagowska-Klimek I; Pietrzykowski W; Moll J; Krajewski W; Nowicki M
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1022-8. PubMed ID: 17403606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes.
    Khajehdehi P; Jamal JA; Bastani B
    Clin Nephrol; 2000 Oct; 54(4):351-5. PubMed ID: 11076113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H
    Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control.
    Bellomo R; Farmer M; Bhonagiri S; Porceddu S; Ariens M; M'Pisi D; Ronco C
    Int J Artif Organs; 1999 Mar; 22(3):145-50. PubMed ID: 10357242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management.
    Veenstra J; Krediet RT; Somers R; Arisz L
    Neth J Med; 1994 Nov; 45(5):211-6. PubMed ID: 7830847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous hemodiafiltration in children.
    Bishof NA; Welch TR; Strife CF; Ryckman FC
    Pediatrics; 1990 May; 85(5):819-23. PubMed ID: 2330246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration.
    Farese S; Jakob SM; Kalicki R; Frey FJ; Uehlinger DE
    Artif Organs; 2009 Aug; 33(8):634-40. PubMed ID: 19624581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.
    Abe M; Okada K; Suzuki M; Nagura C; Ishihara Y; Fujii Y; Ikeda K; Kaizu K; Matsumoto K
    Artif Organs; 2010 Apr; 34(4):331-8. PubMed ID: 20420616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood flow rate effects in continuous venovenous hemodiafiltration on blood urea nitrogen and creatinine reduction.
    Gilbert RW
    Nephrol Nurs J; 2000 Oct; 27(5):503-6, 531. PubMed ID: 16649325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome.
    Pichette V; Leblanc M; Bonnardeaux A; Ouimet D; Geadah D; Cardinal J
    Am J Kidney Dis; 1994 Apr; 23(4):591-6. PubMed ID: 8154498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit.
    Chang JW; Yang WS; Seo JW; Lee JS; Lee SK; Park SK
    Scand J Urol Nephrol; 2004; 38(5):417-21. PubMed ID: 15764254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous arteriovenous hemofiltration and hemodiafiltration in a newborn infant with acute kidney insufficiency].
    Berghuis M; Donckerwolcke RA; Van Vught AJ
    Tijdschr Kindergeneeskd; 1991 Feb; 59(1):27-31. PubMed ID: 1903218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous venovenous hemodiafiltration in critically ill patients with acute renal failure].
    Toft P; Felding M; Tønnesen EK
    Ugeskr Laeger; 2000 May; 162(20):2868-71. PubMed ID: 10860424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapies for critically ill pediatric patients.
    Sakarcan A; Karaböcüoğlu M
    Turk J Pediatr; 1995; 37(1):7-13. PubMed ID: 7732612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.